Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-31

Clinical Trial Update: Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ropivacaine and bupivacaine for preemptive analgesia in ankle fracture surgery completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Ankle Fractures, Pain, Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2018-12-31